| Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines | Journal of Extracellular Vesicles | 2018 | 3.6K |
| Hepatocellular carcinoma | Lancet, The | 2018 | 2.4K |
| Identification of the tumour transition states occurring during EMT | Nature | 2018 | 652 |
| Personalised Prehabilitation in High-risk Patients Undergoing Elective Major Abdominal Surgery: A Randomized Blinded Controlled Trial | Annals of Surgery | 2018 | 318 |
| Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease | Gastroenterology | 2018 | 220 |
| Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial | Journal of Hepatology | 2018 | 200 |
| Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs | Gastroenterology | 2018 | 196 |
| A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis | Hepatology | 2018 | 139 |
| Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection | Hepatology | 2018 | 121 |
| Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials | The Lancet Gastroenterology and Hepatology | 2018 | 96 |
| Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study | The Lancet Gastroenterology and Hepatology | 2018 | 94 |
| Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study | American Journal of Gastroenterology | 2018 | 92 |
| High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study | Clinical Gastroenterology and Hepatology | 2018 | 91 |
| Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis | Gastroenterology | 2018 | 90 |
| Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyond | Cancer Treatment Reviews | 2018 | 89 |
| Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab | Gut | 2018 | 84 |
| Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C | Hepatology | 2018 | 83 |
| A199 EFFICACY OF TOFACITINIB RETREATMENT FOR ULCERATIVE COLITIS AFTER TREATMENT INTERRUPTION: RESULTS FROM THE OCTAVE CLINICAL TRIALS | Journal of the Canadian Association of Gastroenterology | 2018 | 78 |
| Development of an index to define overall disease severity in IBD | Gut | 2018 | 73 |
| miRNA-21 ablation protects against liver injury and necroptosis in cholestasis | Cell Death and Differentiation | 2018 | 71 |
| Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study | Journal of Crohn's and Colitis | 2018 | 70 |
| Extracellular Vesicles Secreted by Astroglial Cells Transport Apolipoprotein D to Neurons and Mediate Neuronal Survival Upon Oxidative Stress | Frontiers in Cellular Neuroscience | 2018 | 67 |
| Effects of Bezafibrate on Outcome and Pruritus in Primary Biliary Cholangitis With Suboptimal Ursodeoxycholic Acid Response | American Journal of Gastroenterology | 2018 | 65 |
| Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts | Hepatology Communications | 2018 | 64 |
| Cholesterol impairs autophagy-mediated clearance of amyloid beta while promoting its secretion | Autophagy | 2018 | 62 |
